Production & Sales

12 Jun 2020
- Production & Sales
- Marketing & Sales
Takeda to divest OTC and select non-core assets in Asia Pacific to Celltrion for up to $278m

By PBR Staff Writer

Takeda Pharmaceutical announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescription pharmaceutical products sold exclusively in Asia Pacific to Celltrion Inc. (“Celltrion”), an Incheon, South Korea-based biopharmaceutical company specializing in the research, development and manufacturing of small molecules, biosimilars and innovative drugs.
12 Jun 2020
Drug Discovery
Research & Development
Clinical Trials
PureO₃ Dissolved Ozone Sensor

By victoria.smith

The new pureO₃ Dissolved Ozone Sensor with Intelligent Sensor Management (ISM^®) technology provides robust, reliable measurement with increased stability in pure water applications.
10 Jun 2020
Production & Sales
Manufacturing
FUJIFILM to invest $928m to expand Danish biologics production facility

By PBR Staff Writer

Japan-based FUJIFILM said that it will invest nearly JPY100bn ($928m) towards the expansion of its large-scale biologics production facility in Denmark.
29 May 2020
Drug Discovery
Research & Development
Clinical Trials
ISM Sensors for M800 and M300 Transmitters

By victoria.smith

METTLER TOLEDO Thornton M800 and M300 ISM process analytical instrumentation provides reliable, accurate measurements of conductivity/resistivity, pH/ORP, dissolved oxygen and dissolved ozone. On-board digital measurement and Intelligent Sensor Management (ISM) technology provide the utmost in convenience and control of sensor performance.
14 May 2020
Production & Sales
Manufacturing
Cipla enters into a licensing agreement with Gilead to expand access to Covid-19 treatment

By PBR Staff Writer

Cipla has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine Remdesivir, which has been issued an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) to treat COVID-19 patients.
05 May 2020
Production & Sales
Manufacturing
Arcturus Therapeutics, Catalent announce partnership to manufacture mRNA-based Covid-19 vaccine

By PBR Staff Writer

Arcturus Therapeutics Holdings, a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to protect against the SARS-CoV-2 coronavirus.
01 May 2020
Drug Discovery
Research & Development
Clinical Trials
Default Table Multi-Parameter Transmitter M800

By victoria.smith

The M800 multi-parameter transmitter provides simultaneous monitoring of one, two or four in-line sensors. It offers measurement of pH/ORP, optical DO, amperometric oxygen (DO as well as O2 gas), conductivity, resistivity, TOC, dissolved ozone, flow and turbidity in pure water as well as process applications.
30 Apr 2020
Production & Sales
Manufacturing
Catalent signs agreement with Johnson & Johnson to be US manufacturing partner for lead COVID-19 vaccine candidate

By PBR Staff Writer

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced a collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby Catalent’s Biologics business unit will accelerate availability of manufacturing capacity and prepare for large-scale commercial manufacturing at its facility in Bloomington, Indiana of Johnson & Johnson’s lead vaccine candidate for COVID-19.
21 Apr 2020
Production & Sales
Manufacturing
Wavelength Pharmaceuticals expands supplies of key drug ingredients for critically ill COVID-19 patients

By PBR Staff Writer

Wavelength Pharmaceuticals, a leading supplier of active pharmaceutical ingredients (APIs), today reported that it has greatly expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients.
17 Apr 2020
Drug Discovery
Research & Development
Clinical Trials
5000i – Faster Scale-up of Fermentation Processes

By victoria.smith

The Kluyver Center for Genomics of Industrial Fermentation in Delft, Holland, is a consortium of several different Universities and Research Centres.

Drug Discovery

Research & Development

Southern Research secures NIH funding for drug testing hub

Perceptive, Nucleus partner to support radiopharmaceutical development

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Viatris files applications in Japan for approval of Effexor to treat GAD

Scholar Rock submits application of SMA therapy to FDA

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG

Gerresheimer at CPHI Frankfurt 2025

Suppliers

No data found

Production & Sales

Takeda to divest OTC and select non-core assets in Asia Pacific to Celltrion for up to $278m

PureO₃ Dissolved Ozone Sensor

FUJIFILM to invest $928m to expand Danish biologics production facility

ISM Sensors for M800 and M300 Transmitters

Cipla enters into a licensing agreement with Gilead to expand access to Covid-19 treatment

Arcturus Therapeutics, Catalent announce partnership to manufacture mRNA-based Covid-19 vaccine

Default Table Multi-Parameter Transmitter M800

Catalent signs agreement with Johnson & Johnson to be US manufacturing partner for lead COVID-19 vaccine candidate

Wavelength Pharmaceuticals expands supplies of key drug ingredients for critically ill COVID-19 patients

5000i – Faster Scale-up of Fermentation Processes

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found